Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Eclipse Blood Collection Set

K-Number: K213690 · 2022-10-26

Decision Date2022-10-26
Product CodeJKA
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

Eclipse Blood Collection Set is a medical device manufactured by Eclipse Medcorp, LLC. It received FDA 510(k) clearance on 2022-10-26 under approval number K213690. The device is classified under product code JKA. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Eclipse Blood Collection Set?

Eclipse Blood Collection Set is a medical device that received FDA 510(k) clearance on 2022-10-26. It is manufactured by Eclipse Medcorp, LLC. The 510(k) number is K213690.

When was Eclipse Blood Collection Set approved by the FDA?

Eclipse Blood Collection Set received FDA 510(k) clearance on 2022-10-26, under approval number K213690.

What company makes Eclipse Blood Collection Set?

Eclipse Blood Collection Set is manufactured by Eclipse Medcorp, LLC.

What is the FDA product code for Eclipse Blood Collection Set?

The FDA product code for Eclipse Blood Collection Set is JKA.

Related Clinical Trials

Other Devices by Eclipse Medcorp, LLC

Related Devices (Code: JKA)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.